36555-52-9 Usage
Uses
Used in Pharmaceutical Industry:
(E)-2-(hydroxyimino)acetaldehyde is used as an intermediate in the production of heterocyclic compounds, which are essential in the development of new therapeutic agents. Its role in the synthesis of drugs makes it a valuable compound in the field of medicinal chemistry.
Used in Agricultural Industry:
(E)-2-(hydroxyimino)acetaldehyde is used as a key starting material in the synthesis of agrochemicals, contributing to the development of effective and innovative products for agricultural applications.
Used in Medicinal Chemistry Research:
(E)-2-(hydroxyimino)acetaldehyde is utilized in the development of new therapeutic agents, thanks to its potential applications in medicinal chemistry. Its unique properties make it a promising candidate for the creation of novel treatments and pharmaceuticals.
Used in Organic Chemistry:
(E)-2-(hydroxyimino)acetaldehyde has been studied for its antioxidant and antibacterial properties, making it a valuable compound in the field of organic chemistry. Its multifaceted applications contribute to the advancement of research and development in this domain.
Check Digit Verification of cas no
The CAS Registry Mumber 36555-52-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,5,5 and 5 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 36555-52:
(7*3)+(6*6)+(5*5)+(4*5)+(3*5)+(2*5)+(1*2)=129
129 % 10 = 9
So 36555-52-9 is a valid CAS Registry Number.
36555-52-9Relevant academic research and scientific papers
Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers
Wu, Shengde,Fluxe, Andrew,Janusz, John M.,Sheffer, James B.,Browning, Greg,Blass, Benjamin,Cobum, Keith,Hedges, Richard,Murawsky, Michael,Fang, Bin,Fadayel, Gina M.,Hare, Michelle,Djandjighian, Laurent
, p. 5859 - 5863 (2007/10/03)
A novel class of tetrahydroindolone-derived semicarbazones has been discovered as potent Kv1.5 blockers. In in vitro studies, several compounds exhibited very good potency for blockade of Kv1.5. Compound 8i showed good selectivity for blockade of Kv1.5 vs hERG and L-type calcium channels. In an anesthetized pig model, compounds 8i and 10c increased atrial ERP about 28%, 18%, respectively, in the right atrium without affecting ventricular ERP.
